Patents by Inventor Carol Haber

Carol Haber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibiting formation of atherosclerotic lesions
    Publication number: 20090012020
    Abstract: The invention features a method of inhibiting formation of atherosclerotic lesions by administering to a mammal, e.g., a human patient who has been identified as suffering from or at risk of developing atherosclerosis, a compound that reduces expression or activity of AFABP.
    Type: Application
    Filed: June 4, 2007
    Publication date: January 8, 2009
    Inventors: Mu-En Lee, Mei Lee, Edgar Haber, Carol Haber, Mark A. Perrella, Gokhan S. Hotamisligil
  • Inhibition of vascular smooth muscle cell proliferation
    Publication number: 20020169151
    Abstract: Methods of treating a mammal having a condition characterized by vascular smooth muscle cell proliferation, where the mammal is treated with progesterone or an agonist thereof. Also disclosed are methods of screening compounds useful for inhibiting vascular smooth muscle cell proliferation.
    Type: Application
    Filed: June 28, 2002
    Publication date: November 14, 2002
    Inventors: Edgar Haber, Carol Haber, Wen-Sen Lee
  • Ubiquitination of the transcription factor E2A
    Publication number: 20020128189
    Abstract: Disclosed is a polypeptide termed UBCE2A that catalyzes the covalent attachment of ubiquitin to the transcription factor E2A, thereby triggering the degradation of E2A. Also disclosed are DNAs encoding UBCE2A.
    Type: Application
    Filed: February 16, 2001
    Publication date: September 12, 2002
    Applicant: President and Fellows of Harvard College, a Massachusetts corporation
    Inventors: Choon-Joo Kho, Mu-En Lee, Edgar Haber, Carol Haber
  • Inhibition of vascular smooth muscle cell proliferation
    Patent number: 6440954
    Abstract: Methods of treating a mammal having a condition characterized by vascular smooth muscle cell proliferation, where the mammal is treated with progesterone or an agonist thereof. Also disclosed are methods of screening compounds useful for inhibiting vascular smooth muscle cell proliferation.
    Type: Grant
    Filed: April 16, 1998
    Date of Patent: August 27, 2002
    Assignee: President and Fellows of Harvard College
    Inventors: Carol Haber, Wen-Sen Lee